Gilead Sciences announced an agreement to acquire Arcellx in a $7.8 billion deal.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Why Did ACLX Stock Surge 80% In Pre-Market Today?